Long non-coding RNAs function as competing endogenous RNAs to regulate cancer progression

Progress in Biochemistry and Biophysics

Volumn 43, Issue 3, 2016, Pages 219-225

  Lian, Yu ^a,b   Li, Xia Yu ^b   Tang, Yan Yan ^b   Yang, Li Ting ^b   Li, Xiao Ling ^a,b   Xiong, Wei ^a,b   Li, Gui Yuan ^a,b   Zeng, Zhao Yang ^a,b  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Long non coding RNAs (incRNA); MicroRNA(miRNAs); Tumorigenesis

Indexed keywords

EID: 84981275550     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.16476/j.pibb.2015.0371     Document Type: Review

References (68)

1. Maher B. ENCODE: The human encyclopaedia. Nature, 2012, 489(7414):46-48
2. Xiao K, Yu Z, Li X, et al. Genome-wide analysis of epstein-barr virus (EBV) integration and strain in C666-1 and raji cells. Journal of Cancer, 2016, 7(2):214-224
3. Xu K, Xiong W, Zhou M, et al. Integrating ChlP-sequencing and digital gene expression profiling to identify BRD7 downstream genes and construct their regulating network. Mol Cell Biochem, 2016, 411(1-2):57-71
4. Gong Z, Zhang S, Zhang W, et al. Long non-coding RNAs in cancer. Sci China Life Sci, 2012, 55(12):1120-1124
5. Huang B. Long non-coding RNA: dancing on immune stage. Sci China Life Sci, 2014, 57(6):643-644
6. Bo H, Gong Z, Zhang W, et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget, 2015, 6(24):20404-20418
7. Zeng Z, Bo H, Gong Z, et al. AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis. Tumour Biol, 2015 [Epub ahead of print] (DOI: 10.1007/sl3277-015-3860-x)
8. Zeng Z, Bo H, Gong Z J, et al. Prog Biochem Biophys, 2015, 42(12):1155-1158
9. Zeng Z, Fan S, Zhang X, et al. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma. Clin Transl Oncol, 2016, 18(2):206-211
10. Liao Q, Zeng Z, Guo X, et al. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation. Oncogene, 2014, 33(16):2098-2109
11. Yang Y, Liao Q, Wei F, et al. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One, 2013, 8(5):e62869
12. Zeng Z, Huang H, Zhang W, et al. Nasopharyngeal carcinoma: advances in genomics and molecular genetics. Sci China Life Sci, 2011, 54(10):966-975
13. Zhang W, Fan S, Zou G, et al. Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma. Tumour Biol, 2015, 36(2):675-683
14. Zhang W, Zeng Z, Fan S, et al. Evaluation of the prognostic value of TGF-beta superfamily type I receptor and TGF-beta type II receptor expression in nasopharyngeal carcinoma using high-throughput tissue microarrays. J Mol Histol, 2012, 43(3):297-306
15. Yan Q, Zeng Z, Gong Z, et al. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC. Oncotarget, 2015, 6(39):41766-41782
16. Ding S P, Liu L L, Huang T, et al. Prog Biochem Biophys, 2015, 42(8):689-696
17. Song X, Shan D, Chen J, et al. miRNAs and IncRNA in vascular injury and remodeling. Sci China Life Sci, 2014, 57(8):826-835
18. Zeng Z, Huang H, Huang L, et al. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci, 2014, 57(3):315-326
19. Geisler S, Coller J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol, 2013, 14(11):699-712
20. Wang K C, Chang H Y. Molecular mechanisms of long noncoding RNAs. Molecular cell, 2011, 43(6):904-914
21. Chen X M, Zhang D D, Luo J J, et al. Prog Biochem Biophys, 2014, 41(10):997-1009
22. Zhang W, Huang C, Gong Z, et al. Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma. J Mol Histol, 2013, 44(5):545-554
23. Gong Z, Zhang S, Zeng Z, et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS One, 2014, 9(11): el 10674
24. Yang Y, Umetsu J, Lu Z J. Global signatures of protein binding on structured RNAs in Saccharomyces cerevisiae. Sci China Life Sci, 2014, 57(1):22-35
25. Tang K, Wei F, Bo H, et al. Prog Biochem Biophys, 2014, 41(2):153-162
26. Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell, 2011, 146(3):353-358
27. Wang J, Liu X, Wu H, et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res, 2010, 38(16):5366-5383
28. Liu X H, Sun M, Nie F Q, et al. LncRNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer, 2014, 13(1):92-117
29. Zhou X, Gao Q, Wang J, et al. Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol, 2014, 133(2):333-339
30. Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature, 2010, 465(7301):1033-1038
31. Tay Y, Kats L, Salmena L, et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell, 2011, 147(2):344-357
32. Bartel D P. MicroRNAs: target recognition and regulatory functions. Cell, 2009, 136(2):215-233
33. Karreth F A, Pandolfi P P. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov, 2013, 3(10):1113-1121
34. Hansen T B, Jensen T I, Clausen B H, et al. Natural RNA circles function as efficient microRNA sponges. Nature, 2013, 495(7441):384-388
35. Tay Y, Rinn J, Pandolfi P P. The multilayered complexity of ceRNA crosstalk and competition. Nature, 2014, 505(7483):344-352
36. Song X, Cao G, Jing L, et al. Analysing the relationship between IncRNA and protein-coding gene and the role of IncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med, 2014, 18(6):991-1003
37. Yu G, Yao W, Gumireddy K, et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol Cancer Ther, 2014, 13(12):3086-3097
38. Xia T, Liao Q, Jiang X, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci Rep, 2014, 4:6088
39. Zhou X, Ye F, Yin C, et al. The interaction between MiR-141 and lncRNA-H19 in regulating cell proliferation and migration in gastric cancer. Cell Physiol Biochem, 2015, 36(4):1440-1452
40. Liang W C, Fu W M, Wong C W, et al. The IncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget, 2015, 6(26):22513-22525
41. Sun T, Wong N. Transforming growth factor-beta-induced long noncoding RNA promotes liver cancer metastasis via RNA-RNA crosstalk. Hepatology, 2015, 61(2):722-724
42. Peng W, Si S, Zhang Q, et al. Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression. J Exp Clin Cancer, 2015, 34(1):1
43. Chen C L, Tseng Y W, Wu J C, et al. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and microRNA regulation. Biomaterials, 2015, 44:71-81
44. Hou P, Zhao Y, Li Z, et al. LincRNA-ROR induces epithelial-tomesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis, 2014, 5(6): el287
45. Wang K, Liu C Y, Zhou L Y, et al. APF IncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun, 2015, 6:6779
46. Hanahan D, Weinberg R A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5):646-674
47. Zhang Z, Zhu Z, Watabe K, et al. Negative regulation of IncRNA GAS5 by miR-21. Cell Death Differ, 2013, 20(11):1558-1568
48. Fan M, Li X, Jiang W, et al. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp Ther Med, 2013, 5(4):1143-1146
49. Fullgrabe J, Klionsky D J, Joseph B. The return of the nucleus: transcriptional and epigenetic control of autophagy. Nat Rev Mol Cell Biol, 2014, 15(1):65-74
50. Liu B, Wen X, Cheng Y. Survival or death: disequilibrating the oncogenic and tumor suppressive autophagy in cancer. Cell Death Dis, 2013, 4(10):e892
51. Gibb E A, Brown C J, Lam W L. The functional role of long non-coding RNA in human carcinomas. Mol Cancer, 2011, 10 (38)
52. Li Y W, Wang Y M, Zhang X Y, et al. Prog Biochem Biophys, 2015, 42(3):228-235
53. Chiyomaru T, Fukuhara S, Saini S, et al. Long non-coding RNA HOTAIR is targeted and regulated by miR-141 in human cancer cells. J Biol Chem, 2014, 289(18):12550-12565
54. Ma C, Nong K, Zhu H, et al. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol, 2014, 35(9):9163-9169
55. Matouk I J, Abbasi I, Hochberg A, et al. Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol, 2009, 21(6):688-692
56. Tang J, Zhuo H, Zhang X, et al. A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis, 2014, 5(12): el549
57. Dey N, Das F, Ghosh-Choudhury N, et al. MicroRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion. PLoS One, 2012, 7(6):e37366
58. Xu G, Zhang Y, Wei J, et al. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein kinase-kinase 3. BMC cancer, 2013, 13(1):469
59. Mandal CC, Ghosh-Choudhury T, Dey N, et al. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis, 2012, 33(10):1897-1908
60. Lin J, Teo S, Lam D H, et al. MicroRNA-lOb pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. Cell Death Dis, 2012, 3(10):e398
61. Li Q, Li X, Guo Z, et al. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer. PLoS One, 2012, 7(11):e48278
62. Lin C W, Chang Y L, Chang Y C, et al. MicroKNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun, 2013, 4:1877
63. Liu Y, Cui H, Wang W, et al. Construction of circular miRNA sponges targeting miR-21 or miR-221 and demonstration of their excellent anticancer effects on malignant melanoma cells. Int J Biochem Cell Biol, 2013, 45(11):2643-2650
64. Dylla L, Jedlicka P. Growth-promoting role of the miR-106a 363 cluster in Ewing sarcoma. PLoS One. 2013, 8(4):e63032
65. Ow T J, Sandulache V C, Skinner H D, et al. Integration of cancer genomics with treatment selection. Cancer, 2013, 119(22):3914-3928
66. Liu K, Yan Z, Li Y, et al. Linc2GO: a human lincRNA function annotation resource based on ceRNA hypothesis. Bioinformatics, 2013, 29(17):2221-2222
67. Li J H, Liu S, Zhou H, et al. StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res, 2014, 42 (Database issue):D92-97
68. Das S, Ghosal S, Sen R, et al. InCeDB: database of human long noncoding RNA acting as competing endogenous RNA. PLoS One, 2014, 9(6):e98965